The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma. (Q39140282)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

title

The association between metformin use and oncologic outcomes among surgically treated diabetic patients with localized renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Stephen A Boorjian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

Christine M Lohse

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

Suzanne B Stewart

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

Matthew K Tollefson

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

John C Cheville

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

Bradley C Leibovich

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

R Houston Thompson

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

publication date

19 August 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

67.e15-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft

13 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

AMPK as a therapeutic target in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Diabetes mellitus with obesity is a predictor of recurrence in patients with non-metastatic renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Multi-institutional analysis of localized renal cell carcinoma that demonstrates the impact of diabetic status on prognosis after nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Diabetes Mellitus and Renal Cell Carcinoma - A Hospital Based Study from Kathmandu Valley

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Diabetes and risk of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Diabetes Mellitus is Independently Associated with an Increased Risk of Mortality in Patients with Clear Cell Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

The impact of metformin use on recurrence and cancer-specific survival in clinically localized high-risk renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Metformin is associated with improved survival in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Metformin use and improved response to therapy in rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Activation of the mTOR signaling pathway in renal clear cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.UROLONC.2014.07.008

10.1016/J.UROLONC.2014.07.008

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25153774 AND SRC:MED&resulttype=core&format=json

13 March 2020

1 reference